Clinical trial management system (CTMS) is an end-to-end software solution for planning, development, execution, and charting of clinical trials, which also includes participant information, trial and registration deadlines, and other landmark events.CTMS helps research centers and life sciences organizations attain efficacy and enhanced productivity of clinical trials by facilitating and managing clinical trials. Integrating CTMS with health information systems (HIS) leads to accuracy and economic benefits such as time and human resource saving, one of the primary factors to drive growth of the CTMS market.Additionally, high incidence of diseases has led to increased R&D activities in pharmaceutical, bio sciences, and clinical research sectors, which is offering several opportunities for the CTMS market. The global CTMS market was valued at US$844 million in 2013 and will exhibit an impressive 14% CAGR from 2013 to 2019 to reach US$1848.5 million in 2019.

Browse Full Global Clinical Trial Management System Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html


Software Sub-Segment to Dominate Global Clinical Trial Management Systems Market

The CTMS market is segmented on the basis of delivery modes of CTMS solutions, end users, types of CTMS solutions, components of CTMS solutions, and regional markets.Web-based CTMS solution delivery accounts for the highest revenue generation in the CTMS market. Of all the end users, the pharmaceutical sector accounts for the largest share of the CTMS market. On the basis of components of CTMS solutions, the software segment accounts as the lead revenue generator. The software segment of the market was valued at US$585 million in 2013 and is expected to reach US$1,274.2 million in 2019, growing at a healthy 13.9% CAGR between 2013 and 2019.

State-Funded Clinical Trials and Research to Allow U.S. to Lead Global CTMS Market

In terms of geography, North America accounts as the most active regional market in the overall CTMS market. This is due to the fact that North America has traditionally been supportive to clinical trials and clinical trials in the U.S. are being funded by the National Institute of Health (NIH), academic institutions, government agencies, and healthcare organizations. As per statistics by the U.S. National Institute of Health, approximately 56,981 clinical trials were conducted in the U.S. in 2011.The North American clinical trial management system market will be valued at US$1107.5 million in 2019, increasing from US$514.4 million in 2013, exhibiting a CAGR of 13.6% from 2013 to 2019.


Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/clinical-trial-management-systems-market.htm

Improved Drug Patent Expiration Laws to Propel Asia Pacific CTMS Market

In Europe, mainly in Central European and East European countries, bio sciences and pharmaceutical companies receive abundant support to conduct clinical trials. The CTMS market has consequently grown considerably in the early parts of the ongoing decade and is expected to stay on a strong growth trajectory in the coming years.However, Asia Pacific is poised to be the fastest growing regional segment of the clinical trial management systems market. Escalated medical research and development in the pharmaceutical sector has led to adoption of CTMS in the region. Moreover, improved industry regulatory framework and patent expiration statutes in several countries such as China, India, and Japan have contributed significantly to the growth of the CTMS market in Asia Pacific.Some of the leading companies in the global clinical trial management system market are Oracle Corporation, Merge Healthcare, PAREXEL, and Medidata Solution. Other players offering services in the market are BioClinica, eClinforce, Forte Research, MedNet Solutions, Bio-Optronics, and DSG.

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=544

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.